Skip to main content

J&J's 2,400 Talcum Lawsuits Transfer Request Dismissed

J&J's 2,400 Talcum Lawsuits Transfer Request Dismissed

J&J's 2,400 Talcum Lawsuits Transfer Request Dismissed

Introduction

On May 09, 2019, U.S. District Judge Maryellen Noreika in Wilmington dismissed J&J’s request to transfer 2,400 Talcum lawsuits to a federal court in Delaware. J&J had argued for the transfer last month. J&J wants to appeal for legal rights of its bankrupt talc supplier, Imerys Talc America Inc., to converge the baby powder suits before Noreika in hopes of quicker resolutions of claims that the talc-based product causes cancer.

According to the judge, J&J neither filed for bankruptcy nor established its financial distress. J&J had made the request under the legal procedure that allows personal injury tort and wrongful death claims to be transferred to the district court in the district where the bankruptcy case was filed.

J&J has been facing 14,000 talcum powder lawsuits, each raising a common allegation that asbestos exposure from the company’s talc-based products causes ovarian cancer or mesothelioma. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. overlooks J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!